Bullisch
$2.86
Szenariopreis
$1.110
-0.020 (-1.77%)Zum Schluss
Atlantic American Corporation is an insurance holding company involved, through its subsidiary companies, in specialty markets of the life, health, and property and casualty insurance industries. The Company’s principal insurance subsidiaries are American Southern Insurance Company and American Safety Insurance Company (American Southern) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (Bankers Fidelity) within the life and health insurance industry. American Southern's primary product lines include commercial automobile insurance, general liability insurance, and surety bonds. Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplements and other accident and health insurance products.
Atlantic American Corp (AAME) is not a good buy right now due to significant financial and compliance challenges. The stock has a current price of 1.18, which is down 59.03% year-to-date, indicating a severe decline in value. Additionally, the RSI is at a very low 18.571, suggesting that the stock is oversold, but this is not a strong enough indicator to warrant a buy. The company has also received multiple compliance notices from Nasdaq for failing to file necessary reports, which raises concerns about its operational stability. The main risk is the ongoing compliance issue, which could further impact investor confidence and stock performance.
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

AM Best Places American Southern Insurance Ratings Under Review with Negative Implications

Atlantic American Receives Nasdaq Notice for Filing Delays

AM Best Downgrades Ratings of American Southern Insurance Group

Atlantic American Fails to File Annual Report on Time

Atlantic American Corporation Reports Second Quarter Results for 2025
Atlantic American Corporation is an insurance holding company involved, through its subsidiary companies, in specialty markets of the life, health, and property and casualty insurance industries. The Company’s principal insurance subsidiaries are American Southern Insurance Company and American Safety Insurance Company (American Southern) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (Bankers Fidelity) within the life and health insurance industry. American Southern's primary product lines include commercial automobile insurance, general liability insurance, and surety bonds. Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplements and other accident and health insurance products. It operates in the Financials sector (LIFE INSURANCE industry).
Atlantic American Corp (AAME) is not a good buy right now due to significant financial and compliance challenges. The stock has a current price of 1.18, which is down 59.03% year-to-date, indicating a severe decline in value. Additionally, the RSI is at a very low 18.571, suggesting that the stock is oversold, but this is not a strong enough indicator to warrant a buy. The company has also received multiple compliance notices from Nasdaq for failing to file necessary reports, which raises concerns about its operational stability. The main risk is the ongoing compliance issue, which could further impact investor confidence and stock performance.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.